Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01517802
Title A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

prostate cancer

breast cancer

Therapies

Abiraterone

Age Groups: adult | child | senior
Covered Countries USA | ESP | DEU | BEL


No variant requirements are available.